Viewing Study NCT05762328



Ignite Creation Date: 2024-05-06 @ 6:43 PM
Last Modification Date: 2024-10-26 @ 2:53 PM
Study NCT ID: NCT05762328
Status: RECRUITING
Last Update Posted: 2024-01-11
First Post: 2023-02-28

Brief Title: Duration of Antibiotic Treatment in Community-acquired Pneumonia
Sponsor: Instituto de Investigacion Sanitaria La Fe
Organization: Instituto de Investigacion Sanitaria La Fe

Study Overview

Official Title: Adherence to Clinical Guidelines Regarding the Duration of Antibiotic Treatment in Patients Hospitalized for Community-acquired Pneumonia With Clinical sTability ADAPT Study
Status: RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ADAPT
Brief Summary: International and national clinical guidelines recommend short antibiotic regimens in patients with non-severe community-acquired pneumonia CAP who have reached clinical stability However adherence to these recommendations remains unclear The goals of this quasi-experimental trial are 1 to assess adherence to clinical guidelines in relation to the duration of antibiotic treatment in patients hospitalized for non-severe CAP who have reached clinical stability 2 increase adherence to clinical guidelines and reduce the use of antibiotics in patients hospitalized for non-severe CAP who have achieved clinical stability after at least 5 days of antibiotic treatment

To this end a multicenter prospective study will be carried out over 2 years and divided into 2 phases i during the first year observational phase patients with CAP hospitalized in the participating centers will be recorded to assess objective 1 ii to achieve objective 2 at the beginning of the second year quasi-experimental trial the centers will be randomized into 2 groups of hospitals one of them a control group and the other an intervention group The intervention will consist in automatic reminders through pop-up windows in the computerized prescription software reminding the clinician responsible for each patient of the need to adhere to clinical guidelines regarding the duration of antibiotic treatment in patients with clinical stability
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None